GlassScriptPhysician profile
Dale Choi
NPI 1033498936
$4,151.08
in general payments reported to CMS, 2019-2025
14 companies · $267 in 2025
The $267 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $407 · 2020: $297 · 2021: $631 · 2022: $876 · 2023: $1,230 · 2024: $443 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,298 · Consulting Fee: $610 · Entertainment: $31.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,297.87 |
| Consulting Fee | $610.00 |
| Entertainment | $31.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,324.03 | 2019-2024 | Misight Contact Lens, Myday Contact Lens, Paragon Crt |
| Johnson & Johnson Vision Care, INC. | $1,295.66 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $589.54 | 2019-2024 | Precision 1, Total30 |
| Abbvie INC. | $232.19 | 2022-2024 | Vuity |
| Allergan, INC. | $156.78 | 2021-2022 | |
| Tarsus Pharmaceuticals, INC. | $130.29 | 2024-2025 | Xdemvy |
| Astellas Pharma US INC | $124.90 | 2024 | Izervay |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $106.77 | 2019 | |
| Optos, INC. | $60.58 | 2019-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Abb Con-Cise Optical Group LLC | $36.56 | 2019-2022 | |
| Lkc Technologies, INC. | $27.87 | 2023 | |
| Bausch & Lomb Americas INC. | $27.56 | 2022-2025 | Miebo, Xiidra |
| Biotissue Holdings INC. | $24.97 | 2022 | |
| Eyevance Pharmaceuticals LLC | $13.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dale Choi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.